CL2021002536A1 - Sal de trifosfato fosforamidatos de nucleótidos como compuestos anticancerígenos. - Google Patents
Sal de trifosfato fosforamidatos de nucleótidos como compuestos anticancerígenos.Info
- Publication number
- CL2021002536A1 CL2021002536A1 CL2021002536A CL2021002536A CL2021002536A1 CL 2021002536 A1 CL2021002536 A1 CL 2021002536A1 CL 2021002536 A CL2021002536 A CL 2021002536A CL 2021002536 A CL2021002536 A CL 2021002536A CL 2021002536 A1 CL2021002536 A1 CL 2021002536A1
- Authority
- CL
- Chile
- Prior art keywords
- phosphoramidates
- nucleotides
- anticancer compounds
- triphosphate salt
- triphosphate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1904544.2A GB201904544D0 (en) | 2019-04-01 | 2019-04-01 | Anticancer compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2021002536A1 true CL2021002536A1 (es) | 2022-06-17 |
Family
ID=66443062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2021002536A CL2021002536A1 (es) | 2019-04-01 | 2021-09-29 | Sal de trifosfato fosforamidatos de nucleótidos como compuestos anticancerígenos. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220024963A1 (es) |
| EP (1) | EP3947408B1 (es) |
| JP (1) | JP2022528679A (es) |
| KR (1) | KR20210146960A (es) |
| CN (1) | CN113661169A (es) |
| AU (1) | AU2020251748A1 (es) |
| BR (1) | BR112021019282A2 (es) |
| CA (1) | CA3133894A1 (es) |
| CL (1) | CL2021002536A1 (es) |
| EA (1) | EA202192660A1 (es) |
| GB (1) | GB201904544D0 (es) |
| IL (1) | IL286815A (es) |
| MA (1) | MA55512A (es) |
| MX (1) | MX2021012038A (es) |
| SG (1) | SG11202110344YA (es) |
| WO (1) | WO2020201751A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0317009D0 (en) | 2003-07-21 | 2003-08-27 | Univ Cardiff | Chemical compounds |
| GB0505781D0 (en) | 2005-03-21 | 2005-04-27 | Univ Cardiff | Chemical compounds |
| DK3031812T3 (en) | 2011-03-01 | 2018-09-17 | NuCana plc | CHEMICAL COMPOUNDS |
| IL291927A (en) | 2014-11-28 | 2022-06-01 | NuCana plc | Oligonucleotides containing modified nucleosides |
| JP6735751B2 (ja) * | 2014-12-15 | 2020-08-05 | エモリー ユニバーシティー | Ｂ型肝炎ウイルスの治療のためのホスホルアミデート |
-
2019
- 2019-04-01 GB GBGB1904544.2A patent/GB201904544D0/en not_active Ceased
-
2020
- 2020-04-01 MA MA055512A patent/MA55512A/fr unknown
- 2020-04-01 JP JP2021558759A patent/JP2022528679A/ja not_active Withdrawn
- 2020-04-01 KR KR1020217034209A patent/KR20210146960A/ko unknown
- 2020-04-01 CA CA3133894A patent/CA3133894A1/en active Pending
- 2020-04-01 EP EP20718737.8A patent/EP3947408B1/en active Active
- 2020-04-01 MX MX2021012038A patent/MX2021012038A/es unknown
- 2020-04-01 AU AU2020251748A patent/AU2020251748A1/en not_active Abandoned
- 2020-04-01 SG SG11202110344YA patent/SG11202110344YA/en unknown
- 2020-04-01 EA EA202192660A patent/EA202192660A1/ru unknown
- 2020-04-01 BR BR112021019282A patent/BR112021019282A2/pt unknown
- 2020-04-01 CN CN202080026890.7A patent/CN113661169A/zh not_active Withdrawn
- 2020-04-01 WO PCT/GB2020/050871 patent/WO2020201751A1/en unknown
-
2021
- 2021-09-29 CL CL2021002536A patent/CL2021002536A1/es unknown
- 2021-09-29 IL IL286815A patent/IL286815A/en unknown
- 2021-10-01 US US17/492,301 patent/US20220024963A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL286815A (en) | 2021-10-31 |
| US20220024963A1 (en) | 2022-01-27 |
| CN113661169A (zh) | 2021-11-16 |
| KR20210146960A (ko) | 2021-12-06 |
| AU2020251748A1 (en) | 2021-10-14 |
| EP3947408B1 (en) | 2023-06-07 |
| SG11202110344YA (en) | 2021-10-28 |
| EP3947408A1 (en) | 2022-02-09 |
| WO2020201751A1 (en) | 2020-10-08 |
| CA3133894A1 (en) | 2020-10-08 |
| JP2022528679A (ja) | 2022-06-15 |
| EA202192660A1 (ru) | 2022-01-14 |
| GB201904544D0 (en) | 2019-05-15 |
| BR112021019282A2 (pt) | 2022-02-01 |
| MX2021012038A (es) | 2021-11-03 |
| MA55512A (fr) | 2022-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018003404A1 (es) | Derivados del nucleósido de fosforamidato como agentes anticancer. | |
| EA201692537A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| EA201592075A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| BR112017017396A2 (pt) | derivados substituídos de nucleosídeos substituídos úteis como agentes anticancerígenos | |
| ECSP17072474A (es) | Métodos para tratar infecciones por el virus filoviridae | |
| EA201491493A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| MX2018016331A (es) | Formas cristalinas de compuesto de triazolopirimidina. | |
| EA201690526A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| BR112018010118A2 (pt) | inibidores de cxcr2 | |
| EA201590943A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| EA201491040A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| EA201892769A3 (ru) | Сложные диэфиры ациклических нуклеозидфосфонатов | |
| BR112016029994A2 (pt) | métodos de preparação de análogos de nucleotídeo substituídos | |
| CL2018001672A1 (es) | Formulaciones para derivados de fosforamidato de farmacos nucleosidos. | |
| BR112018075667A2 (pt) | cromatografia de interação hidrofóbica para purificação de oligonucleotídeos | |
| SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| CL2021002536A1 (es) | Sal de trifosfato fosforamidatos de nucleótidos como compuestos anticancerígenos. | |
| BR112017004595A2 (pt) | composição farmacêutica contendo inibidor de transportador de fosfato dependente de sódio | |
| DOP2017000196A (es) | Derivados de tetrahidropiranil benzamida | |
| EA202091218A1 (ru) | Соли дифосфатфосфорамидата нуклеозидов в качестве противораковых соединений |